...
首页> 外文期刊>Molecular medicine reports >MicroRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells
【24h】

MicroRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells

机译:MicroRNA-200c下调XIAP表达以抑制三阴性乳腺癌细胞的增殖并促进其凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Despite advances in the understanding of breast cancer, patients most commonly have a poor prognosis, particularly those with triple negative breast cancer (TNBC). microRNAs (miRNAs) are endogenous non-coding small RNAs, and their aberrant expression is linked to numerous malignancies. In the present study, the expression levels of miR-200c in patients with TNBC were analyzed and it was identified that miR-200c was downregulated in TNBC samples, compared with that in normal adjacent tissues. miR-200c was overexpressed in the TNBC cell line MDA-MB-231 and its functions were studied in vitro and in vivo. An in vitro study revealed that the overexpression of miR-200c inhibited MDA-MB-231 cell proliferation and resulted in the induction of apoptosis. The in vivo data indicated that the overexpression of miR-200c significantly inhibited tumor growth and increased the rate of apoptosis. Target prediction revealed that the X-linked inhibitor of apoptosis (XIAP) had putative complementary sequences to miR-200c, which was confirmed by a dual luciferase reporter assay. Western blot analysis further demonstrated that the expression of XIAP was markedly reduced and that caspase-3 was highly activated by the overexpression of miR-200c. These findings suggested that miR-200c may function as a tumor suppressor gene in TNBC, at least partly via directly targeting XIAP, and may therefore act as a potential therapeutic target in the development of novel treatment strategies for TNBC.
机译:尽管对乳腺癌的理解已有进步,但患者通常预后较差,尤其是三阴性乳腺癌(TNBC)的患者。 microRNA(miRNA)是内源性非编码小RNA,其异常表达与多种恶性肿瘤有关。在本研究中,分析了TNBC患者中miR-200c的表达水平,并确定与正常邻近组织相比,TNBC样品中的miR-200c被下调。 miR-200c在TNBC细胞系MDA-MB-231中过表达,并在体内和体外研究了其功能。一项体外研究表明,miR-200c的过表达抑制了MDA-MB-231细胞的增殖,并诱导了细胞凋亡。体内数据表明miR-200c的过表达显着抑制了肿瘤的生长并增加了细胞凋亡的速率。靶标预测显示,X连锁的凋亡抑制剂(XIAP)具有与miR-200c的假定互补序列,这已通过双重萤光素酶报告基因检测法得以证实。蛋白质印迹分析进一步证明,XIAP的表达明显降低,而miR-200c的过度表达使caspase-3被高度激活。这些发现表明,miR-200c至少部分通过直接靶向XIAP可能在TNBC中起着抑癌基因的作用,因此可能在TNBC新型治疗策略的开发中充当潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号